EFFECT OF CERTOLIZUMAB PEGOL ON SIGNS AND SYMPTOMS OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK RESULTS OF RAPID-AXSPA STUDY

被引：0
|
作者：
Landewe, R. [1 ,2 ]
Rudwaleit, M. [3 ]
van der Heijde, D. [4 ]
Dougados, M. [5 ]
Maksymowych, W. P. [6 ]
Braun, J. [7 ]
Deodhar, A. [8 ]
Stach, C. [9 ]
Hoepken, B. [9 ]
Coteur, G. [10 ]
Kielar, D. [10 ]
Fichtner, A. [9 ]
Arledge, T. [11 ]
Sieper, J. [12 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Internal Med Rheumatol, NL-1105 AZ Amsterdam, Netherlands
[2] Atrium Med Ctr, Heerlen, Netherlands
[3] Endokrinologikum, Berlin, Germany
[4] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[5] Hop Cochin, Dept Rheumatol, F-75674 Paris, France
[6] Univ Alberta, Dept Med, Edmonton, AB, Canada
[7] Rheumazentrum Ruhrgebiet, Herne, Germany
[8] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[9] UCB Pharma, Monheim, Germany
[10] UCB Pharma, Brussels, Belgium
[11] UCB Pharma, Raleigh, NC USA
[12] Univ Hosp Charite, Dept Rheumatol, Berlin, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：86 / 87
页数：2
相关论文
共 50 条
  • [1] CONTINUED IMPROVEMENTS IN WORKPLACE AND HOUSEHOLD PRODUCTIVITY WITH CERTOLIZUMAB PEGOL TREATMENT IN AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 48-WEEK RESULTS FROM THE RAPID-AXSPA STUDY
    van der Heijde, D.
    Braun, J.
    Rudwaleit, M.
    Purcaru, O.
    Kavanaugh, A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A570 - A570
  • [2] RAPID IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS: 24-WEEK RESULTS OF RAPID-AXSPA STUDY
    Sieper, J.
    Kivitz, A.
    van Tubergen, A.
    Deodhar, A.
    Coteur, G.
    Woltering, F.
    Landewe, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 287 - 287
  • [3] LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 96-WEEK OUTCOMES OF THE RAPID-AXSPA TRIAL
    Sieper, J.
    Rudwaleit, M.
    van der Heijde, D.
    Maksymowych, W.
    Dougados, M.
    Mease, P. J.
    Braun, J.
    Deodhar, A.
    Hoepken, B.
    Nurminen, T.
    Landewe, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 719 - 720
  • [4] LONG-TERM MAINTENANCE OF IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 48-WEEK RESULTS OF THE RAPID-AXSPA STUDY
    Sieper, J.
    Kivitz, A.
    van Tubergen, A.
    Deodhar, A.
    Coteur, G.
    Singh, P.
    Landewe, R.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A569 - A569
  • [5] LONG-TERM MAINTENANCE OF IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS AND NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 96-WEEK RESULTS OF THE RAPID-AXSPA STUDY
    Sieper, J.
    Kivitz, A.
    van Tubergen, A.
    Deodhar, A.
    Szegvari, B.
    Nurminen, T.
    Landewe, R.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A385 - A385
  • [6] Effect Of Certolizumab Pegol Over 48 Weeks In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Landewe, Robert B. M.
    Rudwaleit, Martin
    van der Heijde, Desiree M.
    Dougados, Maxime
    Mease, Philip J.
    Reveille, John D.
    Walsh, Jessica
    Kivitz, Alan J.
    Maksymowych, Walter P.
    Braun, Juergen
    Deodhar, Atul A.
    Stach, Christian
    Hoepken, Bengt
    Singh, Pritibha
    Sieper, Joachim
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S767 - S767
  • [7] Effect of Certolizumab Pegol Over 48 Weeks in Patients with Axial Spondyloarthritis, including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Maksymowych, Walter
    Landewe, Robert
    Rudwaleit, Martin
    van der Heijde, Desiree
    Dougados, Maxime
    Mease, Phillip
    Reveille, John
    Walsh, Jessica
    Kivitz, Alan
    Braun, Juergen
    Deodhar, Atul
    Stach, Christian
    Hoepken, Bengt
    Singh, Pritibha
    Sieper, Joachim
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1496 - 1497
  • [8] Effect of Certolizumab Pegol On Signs and Symptoms of Ankylosing Spondyltitis and Non-Radiographic Axial Spondyloarthritis: 24 Week Results of a Double Blind Randomized Placebo-Controlled Phase 3 Axial Spondyloarthritis Study
    Landewe, Robert B. M.
    Rudwaleit, Martin
    van der Heijde, Desiree
    Dougados, Maxime
    Maksymowych, Walter P.
    Braun, Jurgen
    Deodhar, Atul A.
    Stach, Christian
    Hoepken, Bengt
    Coteur, Geoffroy
    Kielar, Danuta
    Fichtner, Andreas
    Arledge, Terri
    Sieper, Joachim
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S336 - S337
  • [9] Safety and Efficacy of Certolizumab Pegol over 204 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
    Deodhar, Atul A.
    Dougados, Maxime
    Landewe, Robert
    Sieper, Joachim
    Maksymowych, Walter
    Rudwaleit, Martin
    van Den Bosch, Filip
    Braun, Juergen
    Mease, Philip J.
    Kivitz, Alan
    Walsh, Jessica
    Davies, Owen
    Hoepken, Bengt
    Peterson, Luke
    van der Heijde, Desiree
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
    Spadaro, A.
    Scarno, A.
    Carboni, A.
    Perrotta, F. M.
    Catalano, C.
    Lubrano, E.
    Valesini, G.
    [J]. REUMATISMO, 2013, 65 (03) : 134 - 137
12345